Humacyte, Inc.
NASDAQ:HUMA
4.68 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -110.776 | -11.965 | -26.477 | -66.524 | -85.422 |
| Depreciation & Amortization
| 7.719 | 8.21 | 8.241 | 8.351 | 6.749 |
| Deferred Income Tax
| 0 | -0.173 | -17.801 | 0.177 | -4.272 |
| Stock Based Compensation
| 6.828 | 6.184 | 10.146 | 4.694 | 4.457 |
| Change In Working Capital
| 6.571 | 1.029 | -0.557 | -2.369 | 0.453 |
| Accounts Receivables
| 0.031 | 0.145 | -0.063 | 0.488 | -0.185 |
| Inventory
| 0 | 0 | -0.181 | -2.257 | -2.434 |
| Accounts Payables
| 4.811 | -0.509 | -0.197 | -0.889 | 2.434 |
| Other Working Capital
| 1.729 | 1.393 | -0.116 | 0.289 | 0.638 |
| Other Non Cash Items
| 16.353 | -74.414 | -54.742 | 0.103 | 1.976 |
| Operating Cash Flow
| -73.305 | -71.129 | -81.19 | -55.568 | -71.787 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -2.28 | -1.048 | -0.22 | -0.318 | -8.125 |
| Acquisitions Net
| 0 | -5.893 | 0 | 0.05 | 0 |
| Purchases Of Investments
| 0 | -10.107 | -8 | 0 | 0 |
| Sales Maturities Of Investments
| 2.107 | 16 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 5.893 | -8 | 0.05 | 0 |
| Investing Cash Flow
| -0.173 | 4.845 | -8.22 | -0.268 | -8.125 |
| Financing Activities: | |||||
| Debt Repayment
| -34.066 | -1.981 | 27.93 | 1.751 | -1.292 |
| Common Stock Issued
| 0.566 | 0.535 | 0.598 | 0.301 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 38.573 | 0.535 | 239.053 | 0.301 | 1.218 |
| Financing Cash Flow
| 4.507 | -1.446 | 266.983 | 2.052 | -0.074 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 173.699 |
| Net Change In Cash
| -68.971 | -67.73 | 177.573 | -53.784 | -79.986 |
| Cash At End Of Period
| 80.801 | 149.772 | 217.502 | 39.929 | 93.713 |